Tag : CanniMed Therapeutics

Business Market Watch

Aurora Cannabis to Debut on the New York Stock Exchange (NYSE) Next Week

Aurora Cannabis Inc. (TSX: ACB) announced this morning that the company will be debuting its common shares on the New York Stock Exchange (“NYSE”), which will begin trading on October 23, 2018. In conjunction with this move Aurora will delist its shares from the OTCQX stock exchange in the United......
Cannabis News Market Watch

Aurora Cannabis Gains Rights to Patented Sublingual Cannabis Delivery Technologies

Aurora Cannabis (TSX: ACB), CanniMed Therapeutics (TSX: CMED), and CTT Pharmaceutical Holdings (OTC: CTTH) have entered into a three-way agreement that will provide Aurora Cannabis the exclusive rights to distribute CTT Pharmaceuticals patented cannabinoid delivery technology. The six patents received by Aurora are related to cannabinoid delivery for pain management......
Cannabis News Global Market Watch

Aurora Cannabis Finalizes Acquisition of CanniMed Therapeutics

Aurora Cannabis (TSX: ACB) (OTCQB: ACBFF) announced this morning that the company has finalized acquisition of 95% of CanniMed Therapeutics (TSX: CMED) outstanding shares to complete “the largest acquisition in cannabis industry history.” Aurora Cannabis plans to acquire the remaining of CanniMeds outstanding shares through compulsory share acquisition. By completing......
Cannabis News Health Hemp News Market Watch

CanniMed Releases New Product Line – CanniMed Topical Cream

On February 28, 2018, CanniMed Therapeutics Inc. (TSX: CMED) announced that the company had started fulfilling orders and shipping CanniMed® Topical Cream Kits to registered patients. This new product was a fusion of CanniMed’s medical cannabis oil with Kalaya™ Carrier Base Gel, created by Avaria Health & Beauty Corp. (“Avaria”),......